Abstract
An orally active ester of carbenicillin was administered to patients with varying degrees of renal dysfunction. The peak serum levels and serum half-life were found to be increased in patients with renal failure. Urine levels, however, in these patients were above the minimum inhibitory concentration for the majority of urinary tract pathogens.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bailey R. R., Koutsaimanis K. G. Oral administration of a new carbenicillin in the treatment of urinary tract infection. Br J Urol. 1972 Apr;44(2):235–239. doi: 10.1111/j.1464-410x.1972.tb10070.x. [DOI] [PubMed] [Google Scholar]
- Bran J. L., Karl D. M., Kaye D. Human pharmacology and clinical evaluation of an oral carbenicillin preparation. Clin Pharmacol Ther. 1971 May-Jun;12(3):525–530. doi: 10.1002/cpt1971123525. [DOI] [PubMed] [Google Scholar]
- Eastwood J. B., Curtis J. R. Carbenicillin administration in patients with severe renal failure. Br Med J. 1968 Feb 24;1(5590):486–487. doi: 10.1136/bmj.1.5590.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Knudsen E. T., Rolinson G. N., Sutherland R. Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea. Br Med J. 1967 Jul 8;3(5557):75–78. doi: 10.1136/bmj.3.5557.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wallace J. F., Atlas E., Bear D. M., Brown N. K., Clark H., Turck M. Evaluation of an indanyl ester of carbenicillin. Antimicrob Agents Chemother (Bethesda) 1970;10:223–226. doi: 10.1128/AAC.10.2.223. [DOI] [PubMed] [Google Scholar]